ANI Pharmaceuticals Targets $1.1B 2026 Revenue as Cortrophin Sales Surge, Gout Launch Set for Midyear [Yahoo! Finance]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Yahoo! Finance
management saying rare disease will drive roughly of 2026 revenue and forecasting $540–$575 million in Cortrophin Gel sales. Cortrophin growth will come from existing indications plus a dedicated acute gouty arthritis sales push launching mid-2026 — ANI is adding about 90 people (˜65 sales reps) to target ~7,000 primary care and podiatry prescribers, aiming for back-half 2026 impact and full-scale contribution in 2027 (ANI estimates a ~285,000 patient TAM in this setting). Operational and clinical catalysts include 70% adoption of a Cortrophin prefilled syringe, a 160-patient Phase IV gout study to support guideline and reimbursement access, and a Q1 insurance reverification/seasonality delay that management expects to largely reverse in Q2 with growth through the year. Interested in ANI Pharmaceuticals, Inc.? Here are five stocks we like better. ANI Pharmaceuticals (NASDAQ:ANIP) executives used a presentation at the Leerink Partners Global Healthcare Conference to outline the
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- Sizing Up ANI Pharmaceuticals (ANIP) After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals, Inc. (ANIP) Presents at Barclays 28th Annual Global Healthcare Conference Transcript [Seeking Alpha]Seeking Alpha
- Insider Trades And Rare Disease Growth Shape ANI Pharmaceuticals Valuation [Yahoo! Finance]Yahoo! Finance
- Generic Pharmaceuticals Q4 Earnings: ANI Pharmaceuticals (NASDAQ:ANIP) Simply the Best [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Q4 2025: Strong Growth, But Execution Risks Emerge [Seeking Alpha]Seeking Alpha
ANIP
Earnings
- 2/27/26 - Beat
ANIP
Sec Filings
- 3/13/26 - Form 4
- 3/13/26 - Form 4
- 3/13/26 - Form 4
- ANIP's page on the SEC website